nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinidine barbiturate—KCNH2—Sunitinib—kidney cancer	0.112	0.281	CbGbCtD
Quinidine barbiturate—CYP2D6—Temsirolimus—kidney cancer	0.107	0.267	CbGbCtD
Quinidine barbiturate—CYP2D6—Pazopanib—kidney cancer	0.0563	0.14	CbGbCtD
Quinidine barbiturate—CYP2D6—Erlotinib—kidney cancer	0.0402	0.1	CbGbCtD
Quinidine barbiturate—CYP2D6—Sorafenib—kidney cancer	0.0327	0.0815	CbGbCtD
Quinidine barbiturate—CYP2D6—Vinblastine—kidney cancer	0.0323	0.0805	CbGbCtD
Quinidine barbiturate—CYP2D6—Doxorubicin—kidney cancer	0.0198	0.0494	CbGbCtD
Quinidine barbiturate—Quinine—CYP1A1—kidney cancer	0.00243	0.287	CrCbGaD
Quinidine barbiturate—Quinidine—CYP1A1—kidney cancer	0.00213	0.252	CrCbGaD
Quinidine barbiturate—KCNK1—nephron tubule—kidney cancer	0.00187	0.138	CbGeAlD
Quinidine barbiturate—KCNK1—renal system—kidney cancer	0.0017	0.125	CbGeAlD
Quinidine barbiturate—KCNK1—kidney—kidney cancer	0.00164	0.121	CbGeAlD
Quinidine barbiturate—KCNK1—cortex of kidney—kidney cancer	0.0016	0.118	CbGeAlD
Quinidine barbiturate—CYP2D6—urine—kidney cancer	0.00155	0.115	CbGeAlD
Quinidine barbiturate—KCNK1—cardiac atrium—kidney cancer	0.00152	0.112	CbGeAlD
Quinidine barbiturate—Quinine—ABCB1—kidney cancer	0.00129	0.152	CrCbGaD
Quinidine barbiturate—Quinidine—ABCB1—kidney cancer	0.00113	0.134	CrCbGaD
Quinidine barbiturate—Phenobarbital—CYP1A1—kidney cancer	0.000966	0.114	CrCbGaD
Quinidine barbiturate—SCN5A—cardiac atrium—kidney cancer	0.000908	0.067	CbGeAlD
Quinidine barbiturate—GABRA2—cortex of kidney—kidney cancer	0.000846	0.0623	CbGeAlD
Quinidine barbiturate—KCNH2—renal system—kidney cancer	0.000624	0.046	CbGeAlD
Quinidine barbiturate—KCNH2—cardiac atrium—kidney cancer	0.000558	0.0412	CbGeAlD
Quinidine barbiturate—Phenobarbital—ABCB1—kidney cancer	0.000513	0.0607	CrCbGaD
Quinidine barbiturate—CYP2D6—renal system—kidney cancer	0.00038	0.028	CbGeAlD
Quinidine barbiturate—CYP2D6—kidney—kidney cancer	0.000368	0.0271	CbGeAlD
Quinidine barbiturate—Hypoglycaemia—Doxorubicin—kidney cancer	0.00029	0.000539	CcSEcCtD
Quinidine barbiturate—Vertigo—Paclitaxel—kidney cancer	0.00029	0.000538	CcSEcCtD
Quinidine barbiturate—Syncope—Paclitaxel—kidney cancer	0.000289	0.000537	CcSEcCtD
Quinidine barbiturate—Lethargy—Doxorubicin—kidney cancer	0.000289	0.000536	CcSEcCtD
Quinidine barbiturate—Leukopenia—Paclitaxel—kidney cancer	0.000289	0.000536	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Sunitinib—kidney cancer	0.000289	0.000536	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Vincristine—kidney cancer	0.000288	0.000535	CcSEcCtD
Quinidine barbiturate—Pruritus—Sorafenib—kidney cancer	0.000288	0.000535	CcSEcCtD
Quinidine barbiturate—Vomiting—Erlotinib—kidney cancer	0.000288	0.000534	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Capecitabine—kidney cancer	0.000287	0.000533	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000286	0.000531	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Vincristine—kidney cancer	0.000286	0.000531	CcSEcCtD
Quinidine barbiturate—Rash—Erlotinib—kidney cancer	0.000285	0.00053	CcSEcCtD
Quinidine barbiturate—Dermatitis—Erlotinib—kidney cancer	0.000285	0.000529	CcSEcCtD
Quinidine barbiturate—Palpitations—Paclitaxel—kidney cancer	0.000285	0.000529	CcSEcCtD
Quinidine barbiturate—Eye disorder—Capecitabine—kidney cancer	0.000284	0.000527	CcSEcCtD
Quinidine barbiturate—Headache—Erlotinib—kidney cancer	0.000283	0.000526	CcSEcCtD
Quinidine barbiturate—Tinnitus—Capecitabine—kidney cancer	0.000283	0.000526	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Paclitaxel—kidney cancer	0.000283	0.000526	CcSEcCtD
Quinidine barbiturate—Constipation—Vincristine—kidney cancer	0.000283	0.000526	CcSEcCtD
Quinidine barbiturate—Pain—Vincristine—kidney cancer	0.000283	0.000526	CcSEcCtD
Quinidine barbiturate—Diplopia—Doxorubicin—kidney cancer	0.000283	0.000526	CcSEcCtD
Quinidine barbiturate—Flushing—Capecitabine—kidney cancer	0.000282	0.000524	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Capecitabine—kidney cancer	0.000282	0.000524	CcSEcCtD
Quinidine barbiturate—Asthenia—Sunitinib—kidney cancer	0.000281	0.000522	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Gemcitabine—kidney cancer	0.00028	0.00052	CcSEcCtD
Quinidine barbiturate—Nausea—Vinblastine—kidney cancer	0.00028	0.000519	CcSEcCtD
Quinidine barbiturate—Somnolence—Gemcitabine—kidney cancer	0.000279	0.000519	CcSEcCtD
Quinidine barbiturate—Convulsion—Paclitaxel—kidney cancer	0.000279	0.000519	CcSEcCtD
Quinidine barbiturate—Affect lability—Doxorubicin—kidney cancer	0.000279	0.000517	CcSEcCtD
Quinidine barbiturate—Nausea—Everolimus—kidney cancer	0.000279	0.000517	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Sorafenib—kidney cancer	0.000278	0.000517	CcSEcCtD
Quinidine barbiturate—Pruritus—Sunitinib—kidney cancer	0.000277	0.000514	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Capecitabine—kidney cancer	0.000275	0.00051	CcSEcCtD
Quinidine barbiturate—Arthralgia—Paclitaxel—kidney cancer	0.000274	0.000509	CcSEcCtD
Quinidine barbiturate—Myalgia—Paclitaxel—kidney cancer	0.000274	0.000509	CcSEcCtD
Quinidine barbiturate—Chest pain—Paclitaxel—kidney cancer	0.000274	0.000509	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Capecitabine—kidney cancer	0.000274	0.000508	CcSEcCtD
Quinidine barbiturate—Anxiety—Paclitaxel—kidney cancer	0.000274	0.000508	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Gemcitabine—kidney cancer	0.000273	0.000507	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Dactinomycin—kidney cancer	0.000273	0.000507	CcSEcCtD
Quinidine barbiturate—Chills—Capecitabine—kidney cancer	0.000273	0.000506	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000273	0.000506	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000271	0.000504	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Vincristine—kidney cancer	0.000271	0.000503	CcSEcCtD
Quinidine barbiturate—Cardiac arrest—Doxorubicin—kidney cancer	0.000269	0.0005	CcSEcCtD
Quinidine barbiturate—Dizziness—Sorafenib—kidney cancer	0.000269	0.0005	CcSEcCtD
Quinidine barbiturate—Pain—Gemcitabine—kidney cancer	0.000269	0.000499	CcSEcCtD
Quinidine barbiturate—Constipation—Gemcitabine—kidney cancer	0.000269	0.000499	CcSEcCtD
Quinidine barbiturate—Nausea—Erlotinib—kidney cancer	0.000269	0.000499	CcSEcCtD
Quinidine barbiturate—Mood swings—Doxorubicin—kidney cancer	0.000268	0.000498	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Sunitinib—kidney cancer	0.000268	0.000497	CcSEcCtD
Quinidine barbiturate—Ataxia—Doxorubicin—kidney cancer	0.000266	0.000494	CcSEcCtD
Quinidine barbiturate—Mental disorder—Capecitabine—kidney cancer	0.000266	0.000494	CcSEcCtD
Quinidine barbiturate—Asthenia—Dactinomycin—kidney cancer	0.000266	0.000494	CcSEcCtD
Quinidine barbiturate—Confusional state—Paclitaxel—kidney cancer	0.000265	0.000492	CcSEcCtD
Quinidine barbiturate—Erythema—Capecitabine—kidney cancer	0.000265	0.000491	CcSEcCtD
Quinidine barbiturate—Malnutrition—Capecitabine—kidney cancer	0.000265	0.000491	CcSEcCtD
Quinidine barbiturate—Oedema—Paclitaxel—kidney cancer	0.000263	0.000488	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Vincristine—kidney cancer	0.000262	0.000486	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Vincristine—kidney cancer	0.000262	0.000486	CcSEcCtD
Quinidine barbiturate—Liver function test abnormal—Doxorubicin—kidney cancer	0.000261	0.000485	CcSEcCtD
Quinidine barbiturate—Dizziness—Sunitinib—kidney cancer	0.000259	0.000481	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Gemcitabine—kidney cancer	0.000259	0.000481	CcSEcCtD
Quinidine barbiturate—Shock—Paclitaxel—kidney cancer	0.000259	0.000481	CcSEcCtD
Quinidine barbiturate—Vomiting—Sorafenib—kidney cancer	0.000259	0.00048	CcSEcCtD
Quinidine barbiturate—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000259	0.00048	CcSEcCtD
Quinidine barbiturate—Abdominal pain upper—Doxorubicin—kidney cancer	0.000259	0.00048	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Paclitaxel—kidney cancer	0.000258	0.000479	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Paclitaxel—kidney cancer	0.000258	0.000478	CcSEcCtD
Quinidine barbiturate—Tachycardia—Paclitaxel—kidney cancer	0.000257	0.000477	CcSEcCtD
Quinidine barbiturate—Rash—Sorafenib—kidney cancer	0.000257	0.000476	CcSEcCtD
Quinidine barbiturate—Dermatitis—Sorafenib—kidney cancer	0.000256	0.000476	CcSEcCtD
Quinidine barbiturate—Breast disorder—Doxorubicin—kidney cancer	0.000256	0.000475	CcSEcCtD
Quinidine barbiturate—Skin disorder—Paclitaxel—kidney cancer	0.000256	0.000474	CcSEcCtD
Quinidine barbiturate—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000255	0.000473	CcSEcCtD
Quinidine barbiturate—Headache—Sorafenib—kidney cancer	0.000255	0.000473	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Paclitaxel—kidney cancer	0.000254	0.000472	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Dactinomycin—kidney cancer	0.000254	0.000471	CcSEcCtD
Quinidine barbiturate—Anorexia—Paclitaxel—kidney cancer	0.000251	0.000466	CcSEcCtD
Quinidine barbiturate—Muscular weakness—Doxorubicin—kidney cancer	0.00025	0.000464	CcSEcCtD
Quinidine barbiturate—Vision blurred—Capecitabine—kidney cancer	0.000249	0.000463	CcSEcCtD
Quinidine barbiturate—Vomiting—Sunitinib—kidney cancer	0.000249	0.000462	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Gemcitabine—kidney cancer	0.000248	0.000461	CcSEcCtD
Quinidine barbiturate—Tremor—Capecitabine—kidney cancer	0.000248	0.00046	CcSEcCtD
Quinidine barbiturate—Rash—Sunitinib—kidney cancer	0.000247	0.000458	CcSEcCtD
Quinidine barbiturate—Dermatitis—Sunitinib—kidney cancer	0.000247	0.000458	CcSEcCtD
Quinidine barbiturate—Hypotension—Paclitaxel—kidney cancer	0.000246	0.000456	CcSEcCtD
Quinidine barbiturate—Headache—Sunitinib—kidney cancer	0.000245	0.000455	CcSEcCtD
Quinidine barbiturate—Asthma—Doxorubicin—kidney cancer	0.000245	0.000454	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Vincristine—kidney cancer	0.000244	0.000453	CcSEcCtD
Quinidine barbiturate—Nausea—Sorafenib—kidney cancer	0.000242	0.000449	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.00024	0.000445	CcSEcCtD
Quinidine barbiturate—Angina pectoris—Doxorubicin—kidney cancer	0.000238	0.000443	CcSEcCtD
Quinidine barbiturate—Vertigo—Capecitabine—kidney cancer	0.000238	0.000441	CcSEcCtD
Quinidine barbiturate—Asthenia—Vincristine—kidney cancer	0.000238	0.000441	CcSEcCtD
Quinidine barbiturate—Syncope—Capecitabine—kidney cancer	0.000237	0.00044	CcSEcCtD
Quinidine barbiturate—Leukopenia—Capecitabine—kidney cancer	0.000237	0.00044	CcSEcCtD
Quinidine barbiturate—Vomiting—Dactinomycin—kidney cancer	0.000236	0.000438	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Paclitaxel—kidney cancer	0.000235	0.000435	CcSEcCtD
Quinidine barbiturate—Somnolence—Paclitaxel—kidney cancer	0.000234	0.000434	CcSEcCtD
Quinidine barbiturate—Palpitations—Capecitabine—kidney cancer	0.000234	0.000434	CcSEcCtD
Quinidine barbiturate—Rash—Dactinomycin—kidney cancer	0.000234	0.000434	CcSEcCtD
Quinidine barbiturate—Nausea—Sunitinib—kidney cancer	0.000233	0.000432	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Capecitabine—kidney cancer	0.000233	0.000432	CcSEcCtD
Quinidine barbiturate—Pancytopenia—Doxorubicin—kidney cancer	0.000232	0.000431	CcSEcCtD
Quinidine barbiturate—Neutropenia—Doxorubicin—kidney cancer	0.000229	0.000425	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Paclitaxel—kidney cancer	0.000229	0.000425	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000227	0.000422	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Vincristine—kidney cancer	0.000227	0.000421	CcSEcCtD
Quinidine barbiturate—Asthenia—Gemcitabine—kidney cancer	0.000225	0.000419	CcSEcCtD
Quinidine barbiturate—Arthralgia—Capecitabine—kidney cancer	0.000225	0.000418	CcSEcCtD
Quinidine barbiturate—Myalgia—Capecitabine—kidney cancer	0.000225	0.000418	CcSEcCtD
Quinidine barbiturate—Chest pain—Capecitabine—kidney cancer	0.000225	0.000418	CcSEcCtD
Quinidine barbiturate—Pain—Paclitaxel—kidney cancer	0.000225	0.000418	CcSEcCtD
Quinidine barbiturate—Constipation—Paclitaxel—kidney cancer	0.000225	0.000418	CcSEcCtD
Quinidine barbiturate—Anxiety—Capecitabine—kidney cancer	0.000224	0.000417	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000224	0.000415	CcSEcCtD
Quinidine barbiturate—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000223	0.000415	CcSEcCtD
Quinidine barbiturate—Pruritus—Gemcitabine—kidney cancer	0.000222	0.000413	CcSEcCtD
Quinidine barbiturate—Nausea—Dactinomycin—kidney cancer	0.00022	0.000409	CcSEcCtD
Quinidine barbiturate—Dizziness—Vincristine—kidney cancer	0.000219	0.000407	CcSEcCtD
Quinidine barbiturate—Drowsiness—Doxorubicin—kidney cancer	0.000218	0.000405	CcSEcCtD
Quinidine barbiturate—Confusional state—Capecitabine—kidney cancer	0.000218	0.000404	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Paclitaxel—kidney cancer	0.000217	0.000402	CcSEcCtD
Quinidine barbiturate—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000216	0.000402	CcSEcCtD
Quinidine barbiturate—Oedema—Capecitabine—kidney cancer	0.000216	0.000401	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000215	0.000399	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Gemcitabine—kidney cancer	0.000215	0.000399	CcSEcCtD
Quinidine barbiturate—Renal failure—Doxorubicin—kidney cancer	0.000215	0.000398	CcSEcCtD
Quinidine barbiturate—Jaundice—Doxorubicin—kidney cancer	0.000213	0.000395	CcSEcCtD
Quinidine barbiturate—Shock—Capecitabine—kidney cancer	0.000212	0.000394	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Capecitabine—kidney cancer	0.000212	0.000393	CcSEcCtD
Quinidine barbiturate—Thrombocytopenia—Capecitabine—kidney cancer	0.000211	0.000392	CcSEcCtD
Quinidine barbiturate—Tachycardia—Capecitabine—kidney cancer	0.000211	0.000391	CcSEcCtD
Quinidine barbiturate—Vomiting—Vincristine—kidney cancer	0.000211	0.000391	CcSEcCtD
Quinidine barbiturate—Skin disorder—Capecitabine—kidney cancer	0.00021	0.000389	CcSEcCtD
Quinidine barbiturate—Sweating—Doxorubicin—kidney cancer	0.000209	0.000388	CcSEcCtD
Quinidine barbiturate—Urticaria—Paclitaxel—kidney cancer	0.000209	0.000388	CcSEcCtD
Quinidine barbiturate—Rash—Vincristine—kidney cancer	0.000209	0.000388	CcSEcCtD
Quinidine barbiturate—Hyperhidrosis—Capecitabine—kidney cancer	0.000209	0.000387	CcSEcCtD
Quinidine barbiturate—Dermatitis—Vincristine—kidney cancer	0.000209	0.000387	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Paclitaxel—kidney cancer	0.000208	0.000386	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Paclitaxel—kidney cancer	0.000208	0.000386	CcSEcCtD
Quinidine barbiturate—Headache—Vincristine—kidney cancer	0.000208	0.000385	CcSEcCtD
Quinidine barbiturate—Anorexia—Capecitabine—kidney cancer	0.000206	0.000382	CcSEcCtD
Quinidine barbiturate—Agranulocytosis—Doxorubicin—kidney cancer	0.000204	0.000378	CcSEcCtD
Quinidine barbiturate—Hypotension—Capecitabine—kidney cancer	0.000202	0.000375	CcSEcCtD
Quinidine barbiturate—Vomiting—Gemcitabine—kidney cancer	0.0002	0.000371	CcSEcCtD
Quinidine barbiturate—Bradycardia—Doxorubicin—kidney cancer	0.000199	0.00037	CcSEcCtD
Quinidine barbiturate—Rash—Gemcitabine—kidney cancer	0.000198	0.000368	CcSEcCtD
Quinidine barbiturate—Dermatitis—Gemcitabine—kidney cancer	0.000198	0.000367	CcSEcCtD
Quinidine barbiturate—Haemoglobin—Doxorubicin—kidney cancer	0.000197	0.000366	CcSEcCtD
Quinidine barbiturate—Headache—Gemcitabine—kidney cancer	0.000197	0.000365	CcSEcCtD
Quinidine barbiturate—Nausea—Vincristine—kidney cancer	0.000197	0.000365	CcSEcCtD
Quinidine barbiturate—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000197	0.000365	CcSEcCtD
Quinidine barbiturate—Hepatitis—Doxorubicin—kidney cancer	0.000196	0.000364	CcSEcCtD
Quinidine barbiturate—Haemorrhage—Doxorubicin—kidney cancer	0.000196	0.000364	CcSEcCtD
Quinidine barbiturate—Hypersensitivity—Paclitaxel—kidney cancer	0.000194	0.00036	CcSEcCtD
Quinidine barbiturate—Urinary tract disorder—Doxorubicin—kidney cancer	0.000193	0.000359	CcSEcCtD
Quinidine barbiturate—Dyspnoea—Capecitabine—kidney cancer	0.000192	0.000357	CcSEcCtD
Quinidine barbiturate—Urethral disorder—Doxorubicin—kidney cancer	0.000192	0.000356	CcSEcCtD
Quinidine barbiturate—Visual impairment—Doxorubicin—kidney cancer	0.000189	0.00035	CcSEcCtD
Quinidine barbiturate—Asthenia—Paclitaxel—kidney cancer	0.000189	0.00035	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Capecitabine—kidney cancer	0.000188	0.000348	CcSEcCtD
Quinidine barbiturate—Nausea—Gemcitabine—kidney cancer	0.000187	0.000347	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000186	0.000346	CcSEcCtD
Quinidine barbiturate—Pruritus—Paclitaxel—kidney cancer	0.000186	0.000346	CcSEcCtD
Quinidine barbiturate—Erythema multiforme—Doxorubicin—kidney cancer	0.000185	0.000344	CcSEcCtD
Quinidine barbiturate—Constipation—Capecitabine—kidney cancer	0.000185	0.000343	CcSEcCtD
Quinidine barbiturate—Pain—Capecitabine—kidney cancer	0.000185	0.000343	CcSEcCtD
Quinidine barbiturate—Eye disorder—Doxorubicin—kidney cancer	0.000183	0.00034	CcSEcCtD
Quinidine barbiturate—Tinnitus—Doxorubicin—kidney cancer	0.000183	0.000339	CcSEcCtD
Quinidine barbiturate—Cardiac disorder—Doxorubicin—kidney cancer	0.000182	0.000338	CcSEcCtD
Quinidine barbiturate—Flushing—Doxorubicin—kidney cancer	0.000182	0.000338	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000181	0.0047	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Paclitaxel—kidney cancer	0.00018	0.000334	CcSEcCtD
Quinidine barbiturate—Feeling abnormal—Capecitabine—kidney cancer	0.000178	0.00033	CcSEcCtD
Quinidine barbiturate—Immune system disorder—Doxorubicin—kidney cancer	0.000177	0.000328	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Capecitabine—kidney cancer	0.000177	0.000328	CcSEcCtD
Quinidine barbiturate—Mediastinal disorder—Doxorubicin—kidney cancer	0.000177	0.000328	CcSEcCtD
Quinidine barbiturate—CYP2D6—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000176	0.00458	CbGpPWpGaD
Quinidine barbiturate—Chills—Doxorubicin—kidney cancer	0.000176	0.000326	CcSEcCtD
Quinidine barbiturate—Dizziness—Paclitaxel—kidney cancer	0.000174	0.000323	CcSEcCtD
Quinidine barbiturate—Mental disorder—Doxorubicin—kidney cancer	0.000172	0.000319	CcSEcCtD
Quinidine barbiturate—Urticaria—Capecitabine—kidney cancer	0.000172	0.000318	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Capecitabine—kidney cancer	0.000171	0.000317	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Capecitabine—kidney cancer	0.000171	0.000317	CcSEcCtD
Quinidine barbiturate—Erythema—Doxorubicin—kidney cancer	0.000171	0.000317	CcSEcCtD
Quinidine barbiturate—Malnutrition—Doxorubicin—kidney cancer	0.000171	0.000317	CcSEcCtD
Quinidine barbiturate—GRIA2—Neuronal System—ACHE—kidney cancer	0.000168	0.00437	CbGpPWpGaD
Quinidine barbiturate—Tension—Doxorubicin—kidney cancer	0.000167	0.000311	CcSEcCtD
Quinidine barbiturate—Vomiting—Paclitaxel—kidney cancer	0.000167	0.000311	CcSEcCtD
Quinidine barbiturate—Rash—Paclitaxel—kidney cancer	0.000166	0.000308	CcSEcCtD
Quinidine barbiturate—Dermatitis—Paclitaxel—kidney cancer	0.000166	0.000308	CcSEcCtD
Quinidine barbiturate—Nervousness—Doxorubicin—kidney cancer	0.000166	0.000307	CcSEcCtD
Quinidine barbiturate—SCN5A—Developmental Biology—EPAS1—kidney cancer	0.000165	0.00429	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—HNF1A—kidney cancer	0.000165	0.00429	CbGpPWpGaD
Quinidine barbiturate—Headache—Paclitaxel—kidney cancer	0.000165	0.000306	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000164	0.00426	CbGpPWpGaD
Quinidine barbiturate—Vision blurred—Doxorubicin—kidney cancer	0.000161	0.000298	CcSEcCtD
Quinidine barbiturate—GABRA2—Neuronal System—KCNMA1—kidney cancer	0.00016	0.00416	CbGpPWpGaD
Quinidine barbiturate—Hypersensitivity—Capecitabine—kidney cancer	0.000159	0.000295	CcSEcCtD
Quinidine barbiturate—Agitation—Doxorubicin—kidney cancer	0.000157	0.000291	CcSEcCtD
Quinidine barbiturate—Nausea—Paclitaxel—kidney cancer	0.000156	0.00029	CcSEcCtD
Quinidine barbiturate—Asthenia—Capecitabine—kidney cancer	0.000155	0.000288	CcSEcCtD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000154	0.00402	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000154	0.00401	CbGpPWpGaD
Quinidine barbiturate—Vertigo—Doxorubicin—kidney cancer	0.000153	0.000284	CcSEcCtD
Quinidine barbiturate—Syncope—Doxorubicin—kidney cancer	0.000153	0.000284	CcSEcCtD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—TSC2—kidney cancer	0.000153	0.00397	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Capecitabine—kidney cancer	0.000153	0.000284	CcSEcCtD
Quinidine barbiturate—Leukopenia—Doxorubicin—kidney cancer	0.000153	0.000283	CcSEcCtD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.000153	0.00397	CbGpPWpGaD
Quinidine barbiturate—Palpitations—Doxorubicin—kidney cancer	0.000151	0.00028	CcSEcCtD
Quinidine barbiturate—Loss of consciousness—Doxorubicin—kidney cancer	0.00015	0.000278	CcSEcCtD
Quinidine barbiturate—KCNH2—Neuronal System—ACHE—kidney cancer	0.000148	0.00386	CbGpPWpGaD
Quinidine barbiturate—Convulsion—Doxorubicin—kidney cancer	0.000148	0.000274	CcSEcCtD
Quinidine barbiturate—Diarrhoea—Capecitabine—kidney cancer	0.000148	0.000274	CcSEcCtD
Quinidine barbiturate—GRIA2—Neuronal System—BCHE—kidney cancer	0.000146	0.00381	CbGpPWpGaD
Quinidine barbiturate—Myalgia—Doxorubicin—kidney cancer	0.000145	0.00027	CcSEcCtD
Quinidine barbiturate—Arthralgia—Doxorubicin—kidney cancer	0.000145	0.00027	CcSEcCtD
Quinidine barbiturate—Chest pain—Doxorubicin—kidney cancer	0.000145	0.00027	CcSEcCtD
Quinidine barbiturate—Anxiety—Doxorubicin—kidney cancer	0.000145	0.000269	CcSEcCtD
Quinidine barbiturate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000144	0.000268	CcSEcCtD
Quinidine barbiturate—CHRM2—Calcium Regulation in the Cardiac Cell—ITPR2—kidney cancer	0.000143	0.00372	CbGpPWpGaD
Quinidine barbiturate—Dizziness—Capecitabine—kidney cancer	0.000143	0.000265	CcSEcCtD
Quinidine barbiturate—Confusional state—Doxorubicin—kidney cancer	0.00014	0.000261	CcSEcCtD
Quinidine barbiturate—Oedema—Doxorubicin—kidney cancer	0.000139	0.000258	CcSEcCtD
Quinidine barbiturate—Vomiting—Capecitabine—kidney cancer	0.000137	0.000255	CcSEcCtD
Quinidine barbiturate—Shock—Doxorubicin—kidney cancer	0.000137	0.000254	CcSEcCtD
Quinidine barbiturate—Nervous system disorder—Doxorubicin—kidney cancer	0.000136	0.000253	CcSEcCtD
Quinidine barbiturate—GABRA1—Neuronal System—KCNMA1—kidney cancer	0.000136	0.00355	CbGpPWpGaD
Quinidine barbiturate—Thrombocytopenia—Doxorubicin—kidney cancer	0.000136	0.000253	CcSEcCtD
Quinidine barbiturate—Rash—Capecitabine—kidney cancer	0.000136	0.000253	CcSEcCtD
Quinidine barbiturate—Dermatitis—Capecitabine—kidney cancer	0.000136	0.000252	CcSEcCtD
Quinidine barbiturate—Tachycardia—Doxorubicin—kidney cancer	0.000136	0.000252	CcSEcCtD
Quinidine barbiturate—Headache—Capecitabine—kidney cancer	0.000135	0.000251	CcSEcCtD
Quinidine barbiturate—Skin disorder—Doxorubicin—kidney cancer	0.000135	0.000251	CcSEcCtD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—APC—kidney cancer	0.000135	0.00351	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000135	0.0035	CbGpPWpGaD
Quinidine barbiturate—Hyperhidrosis—Doxorubicin—kidney cancer	0.000135	0.00025	CcSEcCtD
Quinidine barbiturate—SCN5A—Developmental Biology—HNF1B—kidney cancer	0.000135	0.0035	CbGpPWpGaD
Quinidine barbiturate—Anorexia—Doxorubicin—kidney cancer	0.000133	0.000246	CcSEcCtD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000132	0.00343	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000131	0.00341	CbGpPWpGaD
Quinidine barbiturate—Hypotension—Doxorubicin—kidney cancer	0.00013	0.000241	CcSEcCtD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	0.00013	0.00337	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—BCHE—kidney cancer	0.000129	0.00336	CbGpPWpGaD
Quinidine barbiturate—Nausea—Capecitabine—kidney cancer	0.000128	0.000238	CcSEcCtD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000128	0.00333	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000127	0.0033	CbGpPWpGaD
Quinidine barbiturate—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000127	0.000235	CcSEcCtD
Quinidine barbiturate—KCNK1—Neuronal System—MAPK1—kidney cancer	0.000125	0.00326	CbGpPWpGaD
Quinidine barbiturate—Dyspnoea—Doxorubicin—kidney cancer	0.000124	0.00023	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000124	0.00323	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000124	0.00322	CbGpPWpGaD
Quinidine barbiturate—Somnolence—Doxorubicin—kidney cancer	0.000124	0.00023	CcSEcCtD
Quinidine barbiturate—Decreased appetite—Doxorubicin—kidney cancer	0.000121	0.000225	CcSEcCtD
Quinidine barbiturate—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00012	0.000223	CcSEcCtD
Quinidine barbiturate—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	0.00012	0.00311	CbGpPWpGaD
Quinidine barbiturate—Constipation—Doxorubicin—kidney cancer	0.000119	0.000221	CcSEcCtD
Quinidine barbiturate—Pain—Doxorubicin—kidney cancer	0.000119	0.000221	CcSEcCtD
Quinidine barbiturate—GABRA2—Neuronal System—ACHE—kidney cancer	0.000118	0.00308	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000115	0.00298	CbGpPWpGaD
Quinidine barbiturate—Feeling abnormal—Doxorubicin—kidney cancer	0.000115	0.000213	CcSEcCtD
Quinidine barbiturate—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000114	0.000211	CcSEcCtD
Quinidine barbiturate—SCN5A—Axon guidance—PAK1—kidney cancer	0.000112	0.00292	CbGpPWpGaD
Quinidine barbiturate—Urticaria—Doxorubicin—kidney cancer	0.000111	0.000205	CcSEcCtD
Quinidine barbiturate—Abdominal pain—Doxorubicin—kidney cancer	0.00011	0.000204	CcSEcCtD
Quinidine barbiturate—Body temperature increased—Doxorubicin—kidney cancer	0.00011	0.000204	CcSEcCtD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	0.000108	0.00282	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PAK1—kidney cancer	0.000108	0.0028	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—RAF1—kidney cancer	0.000106	0.00276	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—RELA—kidney cancer	0.000105	0.00274	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000104	0.0027	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000104	0.0027	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000104	0.0027	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—MTOR—kidney cancer	0.000103	0.00269	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—BCHE—kidney cancer	0.000103	0.00268	CbGpPWpGaD
Quinidine barbiturate—Hypersensitivity—Doxorubicin—kidney cancer	0.000103	0.00019	CcSEcCtD
Quinidine barbiturate—GABRA1—Neuronal System—ACHE—kidney cancer	0.000101	0.00263	CbGpPWpGaD
Quinidine barbiturate—Asthenia—Doxorubicin—kidney cancer	9.99e-05	0.000185	CcSEcCtD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	9.85e-05	0.00256	CbGpPWpGaD
Quinidine barbiturate—Pruritus—Doxorubicin—kidney cancer	9.85e-05	0.000183	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—BRAF—kidney cancer	9.75e-05	0.00254	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	9.72e-05	0.00253	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—EGR1—kidney cancer	9.71e-05	0.00252	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CTNNA1—kidney cancer	9.64e-05	0.00251	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—OR4C13—kidney cancer	9.63e-05	0.00251	CbGpPWpGaD
Quinidine barbiturate—SCN5A—L1CAM interactions—MAPK3—kidney cancer	9.62e-05	0.0025	CbGpPWpGaD
Quinidine barbiturate—Diarrhoea—Doxorubicin—kidney cancer	9.52e-05	0.000177	CcSEcCtD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—JUN—kidney cancer	9.24e-05	0.0024	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PAX6—kidney cancer	9.23e-05	0.0024	CbGpPWpGaD
Quinidine barbiturate—Dizziness—Doxorubicin—kidney cancer	9.2e-05	0.000171	CcSEcCtD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—CTNNB1—kidney cancer	9.17e-05	0.00238	CbGpPWpGaD
Quinidine barbiturate—SCN5A—L1CAM interactions—MAPK1—kidney cancer	9.16e-05	0.00238	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	9.14e-05	0.00238	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	8.85e-05	0.0023	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ANXA2—kidney cancer	8.85e-05	0.0023	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ATP7B—kidney cancer	8.85e-05	0.0023	CbGpPWpGaD
Quinidine barbiturate—Vomiting—Doxorubicin—kidney cancer	8.85e-05	0.000164	CcSEcCtD
Quinidine barbiturate—GABRA1—Neuronal System—BCHE—kidney cancer	8.79e-05	0.00229	CbGpPWpGaD
Quinidine barbiturate—Rash—Doxorubicin—kidney cancer	8.78e-05	0.000163	CcSEcCtD
Quinidine barbiturate—Dermatitis—Doxorubicin—kidney cancer	8.77e-05	0.000163	CcSEcCtD
Quinidine barbiturate—CHRM2—Signaling by GPCR—OR4C13—kidney cancer	8.75e-05	0.00228	CbGpPWpGaD
Quinidine barbiturate—Headache—Doxorubicin—kidney cancer	8.72e-05	0.000162	CcSEcCtD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—HIF1A—kidney cancer	8.63e-05	0.00224	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—ANXA1—kidney cancer	8.33e-05	0.00217	CbGpPWpGaD
Quinidine barbiturate—Nausea—Doxorubicin—kidney cancer	8.27e-05	0.000153	CcSEcCtD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—RAF1—kidney cancer	8.14e-05	0.00212	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—PAK1—kidney cancer	8e-05	0.00208	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	7.99e-05	0.00208	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—JUN—kidney cancer	7.9e-05	0.00205	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	7.84e-05	0.00204	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—kidney cancer	7.79e-05	0.00203	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—JUN—kidney cancer	7.65e-05	0.00199	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—MAPK3—kidney cancer	7.63e-05	0.00199	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	7.63e-05	0.00198	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	7.6e-05	0.00198	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—BRAF—kidney cancer	7.47e-05	0.00194	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	7.43e-05	0.00193	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.34e-05	0.00191	CbGpPWpGaD
Quinidine barbiturate—GRIA2—BDNF signaling pathway—MAPK1—kidney cancer	7.26e-05	0.00189	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTT1—kidney cancer	7.02e-05	0.00183	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—KDR—kidney cancer	6.98e-05	0.00182	CbGpPWpGaD
Quinidine barbiturate—SCN5A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	6.9e-05	0.00179	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—BRAF—kidney cancer	6.87e-05	0.00179	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MET—kidney cancer	6.83e-05	0.00178	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Ion channel transport—RAF1—kidney cancer	6.79e-05	0.00177	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—HIF1A—kidney cancer	6.75e-05	0.00176	CbGpPWpGaD
Quinidine barbiturate—KCNH2—SIDS Susceptibility Pathways—VEGFA—kidney cancer	6.69e-05	0.00174	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	6.62e-05	0.00172	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—BRAF—kidney cancer	6.6e-05	0.00172	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—PTGS1—kidney cancer	6.58e-05	0.00171	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—kidney cancer	6.5e-05	0.00169	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—RAF1—kidney cancer	6.24e-05	0.00162	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—APC—kidney cancer	6.17e-05	0.00161	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.95e-05	0.00155	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—BRAF—kidney cancer	5.86e-05	0.00152	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—BRAF—kidney cancer	5.8e-05	0.00151	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Ion channel transport—RAF1—kidney cancer	5.79e-05	0.00151	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—RAF1—kidney cancer	5.73e-05	0.00149	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.59e-05	0.00145	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—RAF1—kidney cancer	5.51e-05	0.00143	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	5.48e-05	0.00142	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	5.29e-05	0.00138	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—BRAF—kidney cancer	5.26e-05	0.00137	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	5.23e-05	0.00136	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—JUN—kidney cancer	5.2e-05	0.00135	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—OR4C13—kidney cancer	5.17e-05	0.00134	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	5.16e-05	0.00134	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—RAF1—kidney cancer	5.05e-05	0.00131	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—ANXA1—kidney cancer	5.04e-05	0.00131	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—ERBB2—kidney cancer	4.99e-05	0.0013	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KDR—kidney cancer	4.98e-05	0.0013	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—RAF1—kidney cancer	4.89e-05	0.00127	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MET—kidney cancer	4.87e-05	0.00127	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTP1—kidney cancer	4.87e-05	0.00127	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—RAF1—kidney cancer	4.84e-05	0.00126	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	4.8e-05	0.00125	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	4.67e-05	0.00121	CbGpPWpGaD
Quinidine barbiturate—GABRA1—SIDS Susceptibility Pathways—VEGFA—kidney cancer	4.55e-05	0.00118	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	4.51e-05	0.00117	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—BRAF—kidney cancer	4.49e-05	0.00117	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—GSTM1—kidney cancer	4.47e-05	0.00116	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—kidney cancer	4.46e-05	0.00116	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	4.41e-05	0.00115	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—RAF1—kidney cancer	4.39e-05	0.00114	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—LATS1—kidney cancer	4.39e-05	0.00114	CbGpPWpGaD
Quinidine barbiturate—GRIA2—Neuronal System—MAPK1—kidney cancer	4.28e-05	0.00111	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	4.24e-05	0.0011	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	4.18e-05	0.00109	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—ABCB1—kidney cancer	4.18e-05	0.00109	CbGpPWpGaD
Quinidine barbiturate—CHRM2—G alpha (i) signalling events—POMC—kidney cancer	4.08e-05	0.00106	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—JUN—kidney cancer	4.07e-05	0.00106	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	4.04e-05	0.00105	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—AKAP13—kidney cancer	4e-05	0.00104	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.93e-05	0.00102	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—VEGFA—kidney cancer	3.84e-05	0.001	CbGpPWpGaD
Quinidine barbiturate—KCNH2—Neuronal System—MAPK1—kidney cancer	3.78e-05	0.000983	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—RAF1—kidney cancer	3.75e-05	0.000975	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AMER1—kidney cancer	3.74e-05	0.000972	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ACY1—kidney cancer	3.73e-05	0.000971	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MAPK3—kidney cancer	3.64e-05	0.000946	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—AKAP13—kidney cancer	3.63e-05	0.000945	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—RAF1—kidney cancer	3.6e-05	0.000936	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—RELA—kidney cancer	3.58e-05	0.000932	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—ERBB2—kidney cancer	3.56e-05	0.000926	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—ABCB1—kidney cancer	3.56e-05	0.000926	CbGpPWpGaD
Quinidine barbiturate—CHRM2—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.56e-05	0.000926	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—MAPK3—kidney cancer	3.49e-05	0.000908	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—MAPK1—kidney cancer	3.46e-05	0.0009	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ITPR2—kidney cancer	3.4e-05	0.000885	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmission across Chemical Synapses—MAPK1—kidney cancer	3.35e-05	0.000872	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—kidney cancer	3.32e-05	0.000864	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Axon guidance—KRAS—kidney cancer	3.27e-05	0.00085	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	3.24e-05	0.000844	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PDHB—kidney cancer	3.17e-05	0.000825	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Biological oxidations—POMC—kidney cancer	3.16e-05	0.000823	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—KRAS—kidney cancer	3.14e-05	0.000816	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GPC3—kidney cancer	3.13e-05	0.000814	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CER1—kidney cancer	3.13e-05	0.000814	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—CTNNB1—kidney cancer	3.12e-05	0.000811	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ITPR2—kidney cancer	3.09e-05	0.000803	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Neuronal System—MAPK1—kidney cancer	3.01e-05	0.000784	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CCBL1—kidney cancer	2.98e-05	0.000776	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—kidney cancer	2.88e-05	0.00075	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—ANXA1—kidney cancer	2.85e-05	0.000741	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—VEGFA—kidney cancer	2.74e-05	0.000714	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—SFRP2—kidney cancer	2.66e-05	0.000692	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MAPK3—kidney cancer	2.6e-05	0.000675	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—ANXA1—kidney cancer	2.59e-05	0.000673	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PPAT—kidney cancer	2.59e-05	0.000673	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.59e-05	0.000673	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Neuronal System—MAPK1—kidney cancer	2.57e-05	0.000668	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR ligand binding—POMC—kidney cancer	2.47e-05	0.000643	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—MAPK1—kidney cancer	2.47e-05	0.000642	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—FH—kidney cancer	2.4e-05	0.000625	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—APRT—kidney cancer	2.4e-05	0.000625	CbGpPWpGaD
Quinidine barbiturate—GABRA2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.36e-05	0.000614	CbGpPWpGaD
Quinidine barbiturate—SCN5A—Developmental Biology—KRAS—kidney cancer	2.33e-05	0.000607	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GPC3—kidney cancer	2.26e-05	0.000588	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CA2—kidney cancer	2.2e-05	0.000572	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CASP2—kidney cancer	2.15e-05	0.000558	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—AKAP13—kidney cancer	2.15e-05	0.000558	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALAD—kidney cancer	2.14e-05	0.000557	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.09e-05	0.000544	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.04e-05	0.000532	CbGpPWpGaD
Quinidine barbiturate—GABRA1—Transmembrane transport of small molecules—RAF1—kidney cancer	2.01e-05	0.000524	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—GRB7—kidney cancer	1.96e-05	0.00051	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PGK1—kidney cancer	1.96e-05	0.00051	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.96e-05	0.00051	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—LDHB—kidney cancer	1.92e-05	0.0005	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ITPR2—kidney cancer	1.82e-05	0.000475	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CA9—kidney cancer	1.67e-05	0.000433	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CTNNA1—kidney cancer	1.65e-05	0.00043	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—EIF4EBP1—kidney cancer	1.64e-05	0.000428	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HSPB1—kidney cancer	1.64e-05	0.000428	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PSMD7—kidney cancer	1.53e-05	0.000398	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ANXA1—kidney cancer	1.53e-05	0.000398	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TSC1—kidney cancer	1.53e-05	0.000398	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—FLT1—kidney cancer	1.48e-05	0.000385	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CRABP1—kidney cancer	1.42e-05	0.000369	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—POMC—kidney cancer	1.4e-05	0.000363	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PAK1—kidney cancer	1.37e-05	0.000357	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JUNB—kidney cancer	1.37e-05	0.000357	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ITPR2—kidney cancer	1.32e-05	0.000343	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—POMC—kidney cancer	1.27e-05	0.00033	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ACHE—kidney cancer	1.2e-05	0.000312	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTT1—kidney cancer	1.2e-05	0.000312	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SCARB1—kidney cancer	1.14e-05	0.000296	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS1—kidney cancer	1.13e-05	0.000293	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF2—kidney cancer	1.12e-05	0.000292	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	1.12e-05	0.000291	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PSMD7—kidney cancer	1.1e-05	0.000287	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IGF1R—kidney cancer	1.08e-05	0.000282	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—BCHE—kidney cancer	1.05e-05	0.000272	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—RAF1—kidney cancer	1.05e-05	0.000272	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.03e-05	0.000269	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—IL2—kidney cancer	1.03e-05	0.000268	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—SLC2A1—kidney cancer	9.98e-06	0.00026	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—IL2—kidney cancer	9.37e-06	0.000244	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—HIF1A—kidney cancer	8.93e-06	0.000232	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TSC2—kidney cancer	8.91e-06	0.000232	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KDR—kidney cancer	8.54e-06	0.000222	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTP1—kidney cancer	8.33e-06	0.000217	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—ABCB1—kidney cancer	7.88e-06	0.000205	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KIT—kidney cancer	7.87e-06	0.000205	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—APC—kidney cancer	7.87e-06	0.000205	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—GSTM1—kidney cancer	7.65e-06	0.000199	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	7.54e-06	0.000196	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—POMC—kidney cancer	7.49e-06	0.000195	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—BRAF—kidney cancer	7.4e-06	0.000192	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—CYP1A1—kidney cancer	7.25e-06	0.000189	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	7.17e-06	0.000187	CbGpPWpGaD
Quinidine barbiturate—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	6.85e-06	0.000178	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—KRAS—kidney cancer	6.77e-06	0.000176	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	6.22e-06	0.000162	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RAF1—kidney cancer	6.18e-06	0.000161	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—RELA—kidney cancer	6.15e-06	0.00016	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—ERBB2—kidney cancer	6.11e-06	0.000159	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MTOR—kidney cancer	6.03e-06	0.000157	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	5.66e-06	0.000147	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—IL2—kidney cancer	5.54e-06	0.000144	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—POMC—kidney cancer	5.41e-06	0.000141	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CCND1—kidney cancer	5.4e-06	0.00014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—JUN—kidney cancer	5.39e-06	0.00014	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	5.35e-06	0.000139	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PTEN—kidney cancer	5.21e-06	0.000136	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—VEGFA—kidney cancer	4.71e-06	0.000122	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK3—kidney cancer	4.45e-06	0.000116	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MYC—kidney cancer	4.33e-06	0.000113	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTGS2—kidney cancer	4.31e-06	0.000112	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—MAPK1—kidney cancer	4.24e-06	0.00011	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—KRAS—kidney cancer	4e-06	0.000104	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PTEN—kidney cancer	3.76e-06	9.79e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	3.68e-06	9.56e-05	CbGpPWpGaD
Quinidine barbiturate—CHRM2—Signaling Pathways—TP53—kidney cancer	3.56e-06	9.25e-05	CbGpPWpGaD
Quinidine barbiturate—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.65e-06	6.9e-05	CbGpPWpGaD
